BlackRock Inc., the world's largest asset manager, trims its stake in Boston Scientific Corp. as BSX prepares to release its Q4 results.
BlackRock Inc. (NYSE:BLK) shed some 760,000 shares of its stake in Boston Scientific Corp. (NYSE:BSX) a day before the medical device giant is set to release its annual earnings report to Wall Street.
BlackRock, which controls more than $3.2 trillion in assets, assumed a stake in Natick, Mass.-based Boston Scientific following its purchase of Barclay's Global Investors last December.
According to stock ownership forms filed with the federal Securities & Exchange Commission, BlackRock owned some 76 million shares of BSX stock after the Barclay's buyout, good for a 5.2 percent piece of BSX, making it the firms fourth-largest shareholder.
Insulet Corp.'s fourth-quarter and full-year revenues beat its own and analysts' expectations as it continues its drive toward profitability.
Insulet Corp. (NSDQ:PODD) continued down the road to profitability, increasing its fourth-quarter and full-year revenues and narrowing its net losses by 48.9 percent and 16.1 percent, respectively.
The Bedford, Mass.-based insulin management system maker posted a net loss of $14.9 million, or 42 cents per share, on sales of $20.2 million during the three months ended Dec. 31, 2009, compared with net losses of $29.2 million, or $1.05 per share, on sales of $11.9 million during the fourth quarter of 2008.
Contract manufacturer STD Med Inc. is increasing its footprint in West Bridgewater, Mass., with the purchase of a new, 32,000-square-foot clean room facility.
STD Med Inc. is expanding its footprint outside of its Stoughton, Mass., base with the acquisition of a 32,000-square-foot facility in West Bridgewater.
The contract manufacturer said it will build a clean room facility in the space and hire 50 new workers over the next three years. It is slated to open this summer.
Citing founder Primo Tallarida's recipe for success ("hard work, the American Dream, and luck sure doesn't hurt"), STD Med president Steven Tallarida said the company is pleased to be expanding in spite of difficult economic conditions.
NMT Medical Inc. looks to raise $30 million through a public stock offering to bring its STARFlex cardiac implant to market.
NMT Medical Inc. (NSDQ:NMTI) is looking to raise $30 million through a public stock offering to bring its STARFlex cardiac implant through the regulatory process and into the marketplace.
The Boston-based cardiac implant maker said it needs the money because it's low on cash reserves and heavily leveraged. NMT only has about $9 million in cash reserves and has amassed more than $50 million in debt, according to a prospectus filed with the federal Securities & Exchange Commission.
Wound-healing startup CytoSolv Inc. lands $500,000 in seed money from Rhode Island's Slater Technology Fund to develop its treatment for diabetic ulcers.
Rhode Island's state-backed venture arm, the Slater Technology Fund, is investing $500,000 in Providence-based CytoSolv Inc., which is developing a treatment for diabetic ulcers and other wounds.
The company's technology is based on wound-healing factors derived from choroid plexus, part of the blood/brain barrier that secretes proteins involved in healing into the cerebrospinal fluid.
Boston Scientific Corp. plans to shed nearly 200 jobs from its Emerald Isle operation.
Boston Scientific Corp. (NYSE: BSX) plans to cut 175 jobs from its Galway, Ireland, operations, according to RTE, the Emerald Isle's national television and radio broadcast company.
The news service reported that the Natick, Mass.-based medical devices giant would shed the positions from its facility at Ballybrit, where the firm employs some 3,000 workers.
In June, BSX made a substantial investment in its Galway operations, spending some $128 million to open a new research and development lab. The company anticipated that the new facility would create some 45 jobs in the area over the next five years.
Visage Imaging Inc. names John Danahy to lead its North American sales and services operation.
Visage Imaging Inc. named John Danahy as its general manager for North American sales and service.
Danahy's resumé includes stints at Medsphere, where he was vice president of sales, and McKesson/ALI.
Visage Imaging, a subsidiary of Pro Medicus Ltd. (ASX:PME), provides imaging data management tools to hospitals and imaging centers.
